Thus, inhibiting intracellular AR signaling within prostate cancer cells has been a major focus of prostate cancer research, resulting in a variety of chemical inhibitors targeting AR signaling which are used in the clinic [3]. The gene discussed is AR; the disease is prostate carcinoma.